Authors
Loading...
Randomized trial shows that IgG1 skewing predicts poorer graft survival in sensitized renal transplant recipients, suggesting a potential biomarker.
Griffiths et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: